Skip to content
★ Sign in to follow
DH

Don Hankey

Board Director
Président du Conseil
Bone Biologics Corp
Total declarations
12
Company
1
▲ Purchases (7 ops.)
€174k
▼ Sales (0 ops.)
—

Latest filing published 29 Mar 2023 for Bone Biologics Corp.

Filing timeline

BuySale
Don Hankey

Insider track record

Disclosed buys
7
Disclosed sells
0
Signal history

Closed purchases

Market purchases
7

Not enough history yet: 0 closed purchases, at least 2 are needed.

Purchases by company

Don Hankey: trading record in brief

Don Hankey, listed as board member, appears in our data through filings on Bone Biologics Corp shares, published by SEC (Form 4). Between 17 December 2018 and 13 March 2023, the trades on record add up to 12 filings.

No open-market sale appears; the market trades are 7 purchases worth €174k. The totals exclude 6 filings filed without an amount. A purchase on the market is a deliberate choice to commit personal money, which is why it draws more attention than a grant.

The latest filing, published on 29 March 2023, reports a transaction in Bone Biologics Corp. The last insider purchase was made public on 17 January 2020, 2,487 days ago. Filings reach the SEC (Form 4) feed a median of 4 days after the trade. US insiders must file a Form 4 within two business days of a trade. This summary is built from SEC (Form 4) disclosures alone and does not predict where the share price will go.

Companies and markets linked to Don Hankey

Open company profiles for insider transactions, fundamentals and analyst consensus when available.

Declarations12 total
  • ●
    Chairman of the BoardExecutivesBone Biologics Corp
    0SEC
    500,137 shares0Common StockSEC:0001493152-23-009491:0
  • ●
    Chairman of the BoardExecutivesBone Biologics Corp
    0SEC
    9,361,702 shares0Common StockSEC:0001493152-21-025816:1
  • ●
    Chairman of the BoardExecutivesBone Biologics Corp
    2M USD0SEC
    476,190 shares@ US$5.24Common StockSEC:0001493152-21-025816:2
  • ●
    Chairman of the BoardExecutivesBone Biologics Corp
    0SEC
    1,004,310 shares0Common StockSEC:0001493152-21-025816:3
  • ●
    Chairman of the BoardExecutivesBone Biologics Corp
    15M USD15SEC
    5,928,774 shares@ US$2.50100.0% of flowCommon StockSEC:0001493152-21-025816:0
  • ▲
    Chairman of the BoardExecutivesBone Biologics Corp
    195,000 USD19SEC
    195,000 shares@ US$1.001.3% of flowCommon StockSEC:0001493152-20-000773:0
    Canonical exit: 1 Apr 2020 (T+90)
  • ▲
    Chairman of the BoardExecutivesBone Biologics Corp
    0SEC
    553,191 shares0Common StockSEC:0001493152-19-011866:0
    Canonical exit: 4 Nov 2019 (T+90)
  • ▲
    Chairman of the BoardExecutivesBone Biologics Corp
    0SEC
    85,106 shares0Common StockSEC:0001493152-19-010727:0
    Canonical exit: 13 Oct 2019 (T+90)
  • ▲
    Chairman of the BoardExecutivesBone Biologics Corp
    0SEC
    1,063,830 shares0Common StockSEC:0001493152-19-009561:0
    Canonical exit: 18 Sept 2019 (T+90)
  • ▲
    Chairman of the BoardExecutivesBone Biologics Corp
    0SEC
    1,063,830 shares0Common StockSEC:0001493152-19-008227:0
    Canonical exit: 5 Aug 2019 (T+90)
  • ▲
    Chairman of the BoardExecutivesBone Biologics Corp
    0SEC
    18,009,696 shares0Common StockSEC:0001493152-19-003931:0
    Canonical exit: 17 Mar 2019 (T+90)
  • ▲
    Chairman of the BoardExecutivesBone Biologics Corp
    0SEC
    1,489,362 shares0Common StockSEC:0001493152-19-003931:1
    Canonical exit: 23 Jun 2019 (T+90)

12 of 12 declarations